花青3胺 (Cyanine3 amine)

Cyanine3 Amines

目录号	数量	价格	提前通知时间
110C0	1 mg	$125	现货
210C0	5 mg	$260	现货
410C0	25 mg	$510	现货
510C0	50 mg	$895	现货
610C0	100 mg	$1490	现货

Found better price? Let us know and we will propose the way forward!

Cyanine3 amine 是一种含有游离氨基的官能花菁染料。 Cyanine3 是 Cy3® 的类似物。该试剂的氨基可以与 NHS 酯、羧基（经碳二亚胺活化后）和环氧化物等反应基团共轭。氨基染料以盐形式提供，并具有一定的水溶性。

以ChemDraw格式下载

顾客还购买了这个产品

水溶性磺基-Cyanine3 叠氮化物染料，用于敏感分子和完整生物对象的点击化学标记。

Perylene is an extremely bright and photostable fluorescent label with green fluorescence.

含有非活化羧酸基团，用于 TMR 通道的硼二吡咯亚甲基染料。

外观:
分子量:	627.73
CAS 编号:	2247688-56-6
分子式:	C₃₆H₅₂Cl₂N₄O
IUPAC 名称:	3H-Indolium, 1-[6-[(6-aminohexyl)amino]-6-oxohexyl]-2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propen-1-yl]-3,3-dimethyl-, chloride, hydrochloride (1:1:1)
溶解度:
质量控制:
储存条件:
安全数据表（MSDS）:	下载
	产品规格

Gorshkova, M.; Vanchugova, L.; Osipova, N.; Nikitin, A.; Kotova, J.; Kovalenko, E.; Ermolenko, Y.; Malinovskaya, J.; Kovshova, T.; Gelperina, S. Hybrid DIVEMA/PLGA nanoparticles as the potential drug delivery system. Research Square, 2024, preprint. doi: 10.21203/rs.3.rs-4594368/v1
Ruan, Z.; Li, S.; Grigoropoulos, A.; Amiri, H.; Hilburg, S. L.; Chen, H.; Jayapurna, I.; Jiang, T.; Gu, Z.; Alexander-Katz, A.; Bustamante, C.; Huang, H.; Xu, T. Population-Based Heteropolymer Design to Mimic Protein Mixtures. Nature, 2023, 615(7951), 251–258. doi: 10.1038/s41586-022-05675-0
Nizamov, T. R.; Iliasov, A. R.; Vodopyanov, S. S.; Kozhina, I. V.; Bordyuzhin, I. G.; Zhukov, D. G.; Ivanova, A. V.; Permyakova, E. S.; Mogilnikov, P. S.; Vishnevskiy, D. A.; Shchetinin, I. V.; Abakumov, M. A.; Savchenko, A. G. Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines. Pharmaceutics, 2023, 15(1), 127. doi: 10.3390/pharmaceutics15010127
Malinovskaya, J.; Salami, R.; Valikhov, M.; Vadekhina, V.; Semyonkin, A.; Semkina, A.; Abakumov, M.; Harel, Y.; Levy, E.; Levin, T.; Persky, R.; Chekhonin, V.; Lellouche, J.-P.; Melnikov, P.; Gelperina, S. Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy. International Journal of Molecular Sciences, 2023, 24(1), 627. doi: 10.3390/ijms24010627